Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ronald Geyer

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Molecular Imaging and Biology|June 17, 2025
Preclinical Evaluation of a Near-Infrared Labelled Antibody Targeting the Tumour Associated Xenoantigen N-Glycolyl-Neuraminic Acid GM3 GangliosideKris Barreto, Wendy Bernhard, Darien Toledo, et al.
Chemistry & Biology|November 28, 2009
A genetic screen for isolating "lariat" Peptide inhibitors of protein functionKris Barreto, V M Bharathikumar, Alonso Ricardo, et al.
Scientific Reports|August 4, 2019
A Novel Cell-Penetrating Antibody Fragment Inhibits the DNA Repair Protein RAD51Landon Pastushok, Yongpeng Fu, Leo Lin, et al.
Molecular Pharmaceutics|January 28, 2026
Paired Agent Imaging to Evaluate the Improvement of Affinity-Matured Nimotuzumab K4 and K5 Variants as EGFR-Detecting Optical Imaging AgentsWendy Bernhard, Kris Barreto, Yaima Tundidor, et al.
Chembiochem : a European Journal of Chemical Biology|September 12, 2017
Synthetic Modular Antibody Construction by Using the SpyTag/SpyCatcher Protein-Ligase SystemMd Kausar Alam, Carolina Gonzalez, Wayne Hill, et al.
Experimental Hematology|January 30, 2007
Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpressionStuart A Scott, Ashakumary Lakshimikuttysamma, David P Sheridan, et al.
Theranostics|October 4, 2018
Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenograftsAyman El-Sayed, Wendy Bernhard, Kris Barreto, et al.
Oncotarget|February 22, 2018
Near infrared fluorescence imaging of EGFR expression <i>in vivo</i> using IRDye800CW-nimotuzumabWendy Bernhard, Ayman El-Sayed, Kris Barreto, et al.
Scientific Reports|July 7, 2023
Evaluation of nimotuzumab Fab<sub>2</sub> as an optical imaging agent in EGFR positive cancersWendy Bernhard, Kris Barreto, Darien Toledo, et al.
Journal of Nanobiotechnology|October 18, 2024
Antibody-targeted T cells and natural killer cells for cancer immunotherapyAshley R Sutherland, Brijesh Parlekar, David W Livingstone, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Molecular Imaging and Biology|June 17, 2025
Preclinical Evaluation of a Near-Infrared Labelled Antibody Targeting the Tumour Associated Xenoantigen N-Glycolyl-Neuraminic Acid GM3 GangliosideKris Barreto, Wendy Bernhard, Darien Toledo, et al.
Chemistry & Biology|November 28, 2009
A genetic screen for isolating "lariat" Peptide inhibitors of protein functionKris Barreto, V M Bharathikumar, Alonso Ricardo, et al.
Scientific Reports|August 4, 2019
A Novel Cell-Penetrating Antibody Fragment Inhibits the DNA Repair Protein RAD51Landon Pastushok, Yongpeng Fu, Leo Lin, et al.
Molecular Pharmaceutics|January 28, 2026
Paired Agent Imaging to Evaluate the Improvement of Affinity-Matured Nimotuzumab K4 and K5 Variants as EGFR-Detecting Optical Imaging AgentsWendy Bernhard, Kris Barreto, Yaima Tundidor, et al.
Chembiochem : a European Journal of Chemical Biology|September 12, 2017
Synthetic Modular Antibody Construction by Using the SpyTag/SpyCatcher Protein-Ligase SystemMd Kausar Alam, Carolina Gonzalez, Wayne Hill, et al.
Experimental Hematology|January 30, 2007
Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpressionStuart A Scott, Ashakumary Lakshimikuttysamma, David P Sheridan, et al.
Theranostics|October 4, 2018
Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenograftsAyman El-Sayed, Wendy Bernhard, Kris Barreto, et al.
Oncotarget|February 22, 2018
Near infrared fluorescence imaging of EGFR expression <i>in vivo</i> using IRDye800CW-nimotuzumabWendy Bernhard, Ayman El-Sayed, Kris Barreto, et al.
Scientific Reports|July 7, 2023
Evaluation of nimotuzumab Fab<sub>2</sub> as an optical imaging agent in EGFR positive cancersWendy Bernhard, Kris Barreto, Darien Toledo, et al.
Journal of Nanobiotechnology|October 18, 2024
Antibody-targeted T cells and natural killer cells for cancer immunotherapyAshley R Sutherland, Brijesh Parlekar, David W Livingstone, et al.
Pageof 5